Sort
10,829 grants matching “car t”
Development of chimeric antigen receptor T cells targeting cell surface U5 snRNP for the treatment of acute myeloid leukemia
$402,600Anthony Folawuyi Daniyan · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Exploring the preclinical relevance of therapeutic radiolabeled daratumumab (anti-CD38) in combination with anti-CS1 CAR T cells as a novel combinatorial treatment for multiple myeloma
$402,600Flavia Pichiorri · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Exploring the preclinical relevance of therapeutic radiolabeled daratumumab (anti-CD38) in combination with anti-CS1 CAR T cells as a novel combinatorial treatment for multiple myeloma
$402,600Flavia Pichiorri · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
$402,548Andrea Facciabene · University Of Pennsylvania · R01 · FY2017 · CA
Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.
$402,534David Porter · University Of Pennsylvania · P01 · FY2018 · CA
The role of lncRNAs in P450-mediated drug metabolism and drug-induced liver injury
$402,500Xiao-Bo Zhong · University Of Connecticut Storrs · R35 · FY2025 · GM
Physical Activity Measurement in Toddlers
$402,500Soyang Kwon · Lurie Children'S Hospital Of Chicago · R01 · FY2022 · HL
The role of lncRNAs in P450-mediated drug metabolism and drug-induced liver injury
$402,500Xiao-Bo Zhong · University Of Connecticut Storrs · R35 · FY2022 · GM
The role of lncRNAs in P450-mediated drug metabolism and drug-induced liver injury
$402,500Xiao-Bo Zhong · University Of Connecticut Storrs · R35 · FY2021 · GM
The role of lncRNAs in P450-mediated drug metabolism and drug-induced liver injury
$402,500Xiao-Bo Zhong · University Of Connecticut Storrs · R35 · FY2023 · GM
The role of lncRNAs in P450-mediated drug metabolism and drug-induced liver injury
$402,500Xiao-Bo Zhong · University Of Connecticut Storrs · R35 · FY2024 · GM
Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy
$402,394Benjamin Alan Youngblood · St. Jude Children'S Research Hospital · R01 · FY2023 · CA
Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy
$402,394Benjamin Alan Youngblood · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
Mechanisms of Anesthetic Effects on Tachykinin Induced Airway Tone
$402,335Charles W Emala · Columbia University Health Sciences · R01 · FY2017 · GM
CAREER: Trustworthy Machine Learning from Untrusted Models
$402,229Ting Wang · Suny At Stony Brook · · FY2023 · CSE
CAREER: Knot Theory and Dynamics in Contact Geometry
$402,023John B Etnyre · University Of Pennsylvania · · FY2003 · MPS
Mechanisms Underlying Sexual Minority Health Disparities in the United States
$402,004Claire M Kamp Dush · University Of Minnesota · R01 · FY2020 · HD
Bridging Mechanics and Electrochemistry: Theories and Experiments on Battery Materials
$401,730Kejie Zhao · Purdue University · · FY2017 · ENG
REU Site: Engineering and Computing in Rehabilitation and Assisitve Technologies
$401,721Eric Schearer · Cleveland State University · · FY2017 · ENG
IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): CAR PEPTIDE THERAPEUTIC ADJUVANT FOR PAH TARGETED THERAPY
$401,635David Mann · Vascular Biosciences · N01 · FY2015 · HL
The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma
$401,561Vu Nguyen Ngo · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Engineering HIV-specific T cells that have improved function and persistence
$401,553E. John Wherry · University Of Pennsylvania · U19 · FY2022 · AI
Mechanisms of Enterovirus Entry
$401,537Susan Hafenstein · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2020 · AI
Bioinstructive Scaffolds for Potent and Affordable CAR-T Cell Therapy Against Brain Tumors
$401,426Yevgeny Brudno · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Mechanisms of Enterovirus Entry
$401,419Susan Hafenstein · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · AI